The new 5-year plan aims to improve cancer care in the United Kingdom to "world class" levels and promises treatment within 31 days for every cancer patient. Medscape Medical News
Various techniques for regional chemotherapy are able to achieve 3- to 10-times higher concentrations of the cytostatic agent at the tumor than traditional chemotherapy and increased survival in patients with platinum-refractory recurrent ovarian cancer. Medscape Medical News
Breast cancer risk among BRCA1/2 carriers varies considerably, and it is believed that the risk is influenced by other genetic factors. Medscape Medical News